Filing Details

Accession Number:
0001225208-21-003526
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-23 17:15:03
Reporting Period:
2021-02-19
Accepted Time:
2021-02-23 17:15:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529751 A David Pierce 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp Pres Medsurg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-19 1,484 $38.00 9,660 No 4 S Direct
Common Stock Acquisiton 2021-02-21 2,492 $0.00 12,152 No 4 M Direct
Common Stock Disposition 2021-02-21 1,106 $38.03 11,046 No 4 F Direct
Common Stock Acquisiton 2021-02-22 2,607 $0.00 13,653 No 4 M Direct
Common Stock Disposition 2021-02-22 1,157 $39.20 12,496 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Deferred Stock Units Disposition 2021-02-21 2,492 $0.00 2,492 $0.00
Common Stock Deferred Stock Units Disposition 2021-02-22 2,607 $0.00 2,607 $0.00
Common Stock Performance Share Units Acquisiton 2021-02-22 9,456 $0.00 9,456 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,986 2023-02-21 No 4 M Direct
0 2021-02-22 No 4 M Direct
9,456 2022-12-31 2022-12-31 No 4 A Direct
Footnotes
  1. This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
  4. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
  5. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  6. On February 18, 2020, the reporting person was awarded a target number of performance share units under the Company's 2020 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2020 adjusted free cash flow measured against its 2020 financial plan over the one-year performance period ending December 31, 2020 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2022.